Ophthalmology Glaucoma

metrics 2024

Driving Excellence in Ophthalmology and Patient Outcomes

Introduction

Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.

Metrics 2024

SCIMAGO Journal Rank1.27
Journal Impact Factor2.80
Journal Impact Factor (5 years)3.00
H-Index23
Journal IF Without Self2.80
Eigen Factor0.00
Normal Eigen Factor0.51
Influence1.05
Immediacy Index1.50
Cited Half Life2.80
Citing Half Life8.60
JCI1.25
Total Documents514
WOS Total Citations905
SCIMAGO Total Citations1845
SCIMAGO SELF Citations129
Scopus Journal Rank1.27
Cites / Document (2 Years)2.22
Cites / Document (3 Years)2.21
Cites / Document (4 Years)2.23

Metrics History

Rank 2024

Scopus

Ophthalmology in Medicine
Rank #29/137
Percentile 78.83
Quartile Q1

IF (Web Of Science)

OPHTHALMOLOGY
Rank 23/95
Percentile 76.30
Quartile Q1

JCI (Web Of Science)

OPHTHALMOLOGY
Rank 17/95
Percentile 82.11
Quartile Q1

Quartile History

Similar Journals

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

Advancing the Frontiers of Ophthalmology.
Publisher: GEORG THIEME VERLAG KGISSN: 0023-2165Frequency: 12 issues/year

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

BMC GASTROENTEROLOGY

Exploring New Frontiers in Gastroenterology Research
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Gastroenterology is a premier open-access journal published by BMC, dedicated to disseminating high-quality research in the field of gastroenterology. Established in 2001 and headquartered in the United Kingdom, this journal aims to enhance the understanding of gastrointestinal disorders through innovative research, reviews, and clinical studies. With an impressive impact factor and ranking within the Q2 category in gastroenterology and miscellaneous medicine for 2023, BMC Gastroenterology plays a critical role in advancing knowledge and practices in the field. The journal's commitment to open access ensures that researchers, professionals, and students worldwide can freely access and share vital findings and insights. Encouraging collaboration and knowledge transfer, BMC Gastroenterology is an essential resource for those dedicated to improving gastrointestinal health and outcomes.

INDIAN JOURNAL OF OPHTHALMOLOGY

Empowering Eye Care: Where Research Meets Practice
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0301-4738Frequency: 12 issues/year

The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

JAMA Ophthalmology

Exploring Innovations for Visionary Outcomes
Publisher: AMER MEDICAL ASSOCISSN: 2168-6165Frequency: 12 issues/year

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Journal of the Korean Ophthalmological Society

Nurturing the Future of Ophthalmological Excellence
Publisher: KOREAN OPHTHALMOLOGICAL SOCISSN: 0378-6471Frequency: 12 issues/year

The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

Clinical and Experimental Gastroenterology

Exploring the frontiers of gastroenterology for better patient outcomes.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Urogynecology

Connecting global experts for impactful findings in urogynecology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Urogynecology, published by Lippincott Williams & Wilkins, is a distinguished journal that serves as an essential platform for researchers, clinicians, and students in the fields of obstetrics, gynecology, surgery, and urology. With an impact factor that places it in the Q2 category in various specialties, the journal emphasizes high-quality, peer-reviewed research that contributes to advancements in women's health and pelvic floor disorders. As an Open Access journal, it is committed to enhancing the accessibility of its content, allowing for broader dissemination of knowledge and fostering collaborative efforts in the medical community. Located in India and addressing a global audience, Urogynecology has quickly established its reputation since its inception in 2022, continuing through its converged years until 2024. It is ranked favorably in Scopus across several medical categories, providing a vital resource for cutting-edge research and clinical practice insights. This journal aims to bridge gaps in knowledge and practice, making it an invaluable asset for anyone dedicated to improving outcomes in urogynecology.

Breast Journal

Fostering collaboration for a healthier tomorrow.
Publisher: WILEY-HINDAWIISSN: 1075-122XFrequency: 1 issue/year

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

Prostate Cancer

Elevating knowledge, enhancing lives in prostate cancer.
Publisher: HINDAWI LTDISSN: 2090-3111Frequency: 1 issue/year

Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.

Middle East African Journal of Ophthalmology

Advancing ocular health through innovative research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0974-9233Frequency: 4 issues/year

The Middle East African Journal of Ophthalmology is a distinguished publication dedicated to advancing knowledge in the field of ophthalmology, published by Wolters Kluwer Medknow Publications in India. With a robust focus on contributions that bridge the gap between clinical practices and scientific research, this journal serves as a crucial platform for researchers, practitioners, and students alike. Since its inception, it has consistently disseminated high-impact research, achieving notable recognition with a Q3 ranking in both Medicine (miscellaneous) and Ophthalmology categories as of 2023. Despite being a newer entrant into the scholarly landscape, it features an array of innovative articles, highlighting significant advancements and emerging trends in ocular health. Researchers may access a wealth of knowledge through its open access articles, promoting the dissemination of vital ophthalmic research that is relevant in both Middle Eastern and African contexts. By fostering collaboration and communication among professionals in the field, the Middle East African Journal of Ophthalmology is committed to championing excellence in eye care and elevating the standard of research applicable to global populations.